StoneX Group Inc. - SNEX

SNEX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SNEX	0.2	7.8	13.7	26.8	26.4	47.4	105.8	265.4	733.8	6387.3
S&P 500	0.4	4.7	3.7	12.2	14.8	35.8	29.0	94.2	194.1	33849.8

Compare SNEX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SNEX
name	StoneX Group Inc.
price	97.31
changes percentage	0.23
change	0.22
day low	96.72
day high	98.50
year high	101.62
year low	59.07
market cap	3093611403
price avg 50	84.60
price avg 200	75.55
exchange	NASDAQ
volume	194154
avg volume	125304
open	97.12
previous close	97.09
eps	7.96
pe	12.22
earnings announcement	2024-11-13T00:00:00.000+0000
shares outstanding	31791300
timestamp	2024-11-08 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 45.0%

Overall Quarterly Financial Health: 60.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000913760
revenue	60856100000	4885000000	1,145.77
gross profit	1493000000	1119000000	33.42
gross profit ratio	0.02	0.23	-89.29
research and development expenses	42000000	35000000	20.00
operating expenses	376700000	637000000	-40.86
interest income	987600000	219000000	350.96
interest expense	802200000	135500000	492.03
ebitda	1167300000	602000000	93.90
ebitdaratio	0.02	0.12	-84.44
operating income	1621000000	536000000	202.43
operating income ratio	0.03	0.11	-75.72
net income	238500000	355000000	-32.82
net income ratio	0.0	0.07	-94.61
eps	7.7	12.09	-36.31

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 60,856 million in 2023 from 4,885 million in 2022 representing a change of 1145.77%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,493 million in 2023 from 1,119 million in 2022 representing a change of 33.42%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 42 million in 2023 from 35 million in 2022 representing a change of 20.0%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 377 million in 2023 from 637 million in 2022 representing a change of -40.86%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,167 million in 2023 from 602 million in 2022 representing a change of 93.9%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,621 million in 2023 from 536 million in 2022 representing a change of 202.43%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 238 million in 2023 from 355 million in 2022 representing a change of -32.82%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 7.7 in 2023 from 7.7 in 2022 representing a change of -36.31%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000913760
revenue	27069700000	22106100000	22.45
gross profit	770000000	679500000	13.32
gross profit ratio	0.03	0.03	-7.46
research and development expenses	0	18000000	-100.00
operating expenses	155800000	340500000	-54.24
interest income	379600000	2000000	18,880.00
interest expense	321100000	275400000	16.59
ebitda	425100000	357200000	19.01
ebitdaratio	0.02	0.02	-2.81
operating income	405500000	339000000	19.62
operating income ratio	0.01	0.02	-2.32
net income	61900000	53100000	16.57
net income ratio	0.0	0.0	-4.80
eps	1.95	1.68	16.07

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 27,070 million in 2024Q3 from 22,106 million in 2024Q2 representing a change of 22.45%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 770 million in 2024Q3 from 680 million in 2024Q2 representing a change of 13.32%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 156 million in 2024Q3 from 340 million in 2024Q2 representing a change of -54.24%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 425 million in 2024Q3 from 357 million in 2024Q2 representing a change of 19.01%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 406 million in 2024Q3 from 339 million in 2024Q2 representing a change of 19.62%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 62 million in 2024Q3 from 53 million in 2024Q2 representing a change of 16.57%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.95 in 2024Q3 from 1.95 in 2024Q2 representing a change of 16.07%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 18 million in 2024Q2 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000913760
total assets	21938700000	3443000000	537.20
total liabilities	20559600000	2668000000	670.60
total equity	5617999999	3814000000	47.30
cash and cash equivalents	1108300000	354000000	213.08
short term investments	2426300000	76000000	3,092.50
long term investments	8024300000	151000000	5,214.11
total current assets	13333100000	2326000000	473.22
total non current assets	8605600000	831000000	935.57
total current liabilities	11338700000	1988000000	470.36
total non current liabilities	9220900000	496000000	1,759.05
common stock	200000	899000000	-99.98
retained earnings	1128100000	-119000000	1,047.98
total debt	6476300000	5352300000	21.00

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 21,939 million in 2023 from 3,443 million in 2022 representing a change of 537.2%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 5,618 million in 2023 from 3,814 million in 2022 representing a change of 47.3%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,108 million in 2023 from 354 million in 2022 representing a change of 213.08%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 2,426 million in 2023 from 76 million in 2022 representing a change of 3092.5%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 13,333 million in 2023 from 2,326 million in 2022 representing a change of 473.22%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,128 million in 2023 from -119 million in 2022 representing a change of 1047.98%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 20,560 million in 2023 from 2,668 million in 2022 representing a change of 670.6%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 11,339 million in 2023 from 1,988 million in 2022 representing a change of 470.36%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2023 from 899 in 2022 representing a change of -99.98%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 6,476 million in 2023 from 5,352 million in 2022 representing a change of 21.0%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000913760
total assets	25930800000	25651000000	1.09
total liabilities	24323000000	24108400000	0.89
total equity	1607800000	1542600000	4.23
cash and cash equivalents	2376500000	3098700000	-23.31
short term investments	2750400000	85000000	3,135.76
long term investments	5833200000	9411100000	-38.02
total current assets	19089600000	15586800000	22.47
total non current assets	6841200000	10064200000	-32.02
total current liabilities	11812600000	12339100000	-4.27
total non current liabilities	12510400000	11769300000	6.30
common stock	400000	400000	0.00
retained earnings	1312200000	1250300000	4.95
total debt	9160200000	8791700000	4.19

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 25,931 million in 2024Q3 from 25,651 million in 2024Q2 representing a change of 1.09%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,608 million in 2024Q3 from 1,543 million in 2024Q2 representing a change of 4.23%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 2,750 million in 2024Q3 from 85 million in 2024Q2 representing a change of 3135.76%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 19,090 million in 2024Q3 from 15,587 million in 2024Q2 representing a change of 22.47%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 11,813 million in 2024Q3 from 12,339 million in 2024Q2 representing a change of -4.27%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 1,312 million in 2024Q3 from 1,250 million in 2024Q2 representing a change of 4.95%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 24,323 million in 2024Q3 from 24,108 million in 2024Q2 representing a change of 0.89%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2,376 million in 2024Q3 from 3,099 million in 2024Q2 representing a change of -23.31%. This indicates a decrease in available liquid assets.

  Total Debt: Total Debt increased to 9,160 million in 2024Q3 from 8,792 million in 2024Q2 representing a change of 4.19%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000913760
net change in cash	-243400000	-201000000	-21.09
operating cash flow	-23700000	562000000	-104.22
free cash flow	-70600000	506000000	-113.95
capital expenditure	-46900000	-56000000	16.25
depreciation and amortization	65000000	91000000	-28.57
deferred income tax	-2400000	-300000	-700.00
stock based compensation	28000000	17800000	57.30
accounts payables	163900000	2156500000	-92.40
inventory	-1300000	-67200000	98.07
acquisitions net	-6100000	-200000	-2,950.00
investments in property plant and equipment	-46900000	-56000000	16.25
net cash used for investing activites	-53000000	-226000000	76.55
debt repayment	-341300000	-692800000	50.74
common stock issued	3700000	6700000	-44.78
common stock repurchased	-1152000000	-547000000	-110.60
dividends paid	-12700000	-9600000	-32.29
net cash used provided by financing activities	-169300000	-536000000	68.41
cash at end of period	6041700000	1537000000	293.08
accounts receivables	-80500000	-51000000	-57.84
cash at beginning of period	6285100000	1738000000	261.63

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -243 million in 2023 from -201 million in 2022 representing a change of -21.09%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -24 million in 2023 from 562 million in 2022 representing a change of -104.22%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -71 million in 2023 from 506 million in 2022 representing a change of -113.95%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -47 million in 2023 from -56 million in 2022 representing a change of 16.25%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 28 million in 2023 from 18 million in 2022 representing a change of 57.3%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -13 million in 2023 from -10 million in 2022 representing a change of -32.29%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Payables: The absolute value of Accounts Payables decreased to 164 million in 2023 from 2,156 million in 2022 representing a change of -92.4%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -80 million in 2023 from -51 million in 2022 representing a change of -57.84%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000913760
operating cash flow	-278100000	820100000	-133.91
free cash flow	-296500000	802700000	-136.94
capital expenditure	-18400000	-17400000	-5.75
depreciation and amortization	19600000	18200000	7.69
deferred income tax	-300000	-4800000	93.75
stock based compensation	11000000	9200000	19.57
accounts receivables	108400000	-139200000	177.87
accounts payables	-479400000	1012300000	-147.36
inventory	29500000	-98500000	129.95
acquisitions net	400000	-1100000	136.36
investments in property plant and equipment	-18400000	-17400000	-5.75
net cash used for investing activites	-258899999	-128699999	-101.17
debt repayment	-708000000	-351000000	-101.71
common stock issued	1000000	3000000	-66.67
common stock repurchased	-800000	-30000000	97.33
dividends paid	0	0	NaN
net cash used provided by financing activities	-717400000	896000000	-180.07
net change in cash	-722200000	946600000	-176.29
cash at end of period	2376500000	3098700000	-23.31
cash at beginning of period	3098700000	2152100000	43.98

Overall Score of Quarterly Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -722 million in 2024Q3 from 947 million in 2024Q2 representing a change of -176.29%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -278 million in 2024Q3 from 820 million in 2024Q2 representing a change of -133.91%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -296 million in 2024Q3 from 803 million in 2024Q2 representing a change of -136.94%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q3 from -5 million in 2024Q2 representing a change of 93.75%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 11 million in 2024Q3 from 9 million in 2024Q2 representing a change of 19.57%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 108 in 2024Q3 from -139 million in 2024Q2 representing a change of 177.87%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -18 million in 2024Q3 from -17 million in 2024Q2 representing a change of -5.75%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 479 million in 2024Q3 from 1,012 million in 2024Q2 representing a change of -147.36%. This indicates that the company has reduced its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-09-30	2022-09-30	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	2032.87	166.41	1,121.62
net income per share	7.97	12.09	-34.12
operating cash flow per share	-0.79	19.14	-104.14
free cash flow per share	-2.36	17.24	-113.68
cash per share	118.07	14.65	706.06
book value per share	46.07	26.4	74.50
tangible book value per share	43.32	5.11	747.71
shareholders equity per share	46.07	26.57	73.38
interest debt per share	243.14	38.04	539.21
market cap	1934164830.78	1623071289.87	19.17
enterprise value	7302164830.78	6621371289.87	10.28
pe ratio	8.11	4.57	77.38
price to sales ratio	0.03	0.33	-90.43
pocfratio	-81.61	2.89	-2,925.82
pfcf ratio	-27.4	3.21	-954.09
pb ratio	1.4	2.08	-32.60
ptb ratio	1.4	2.08	-32.60
ev to sales	0.12	1.36	-91.15
enterprise value over ebitda	6.26	11.0	-43.13
ev to operating cash flow	-308.11	11.78	-2,715.12
ev to free cash flow	-103.43	13.09	-890.40
earnings yield	0.12	0.22	-43.62
free cash flow yield	-0.04	0.31	-111.71
debt to equity	4.7	1.26	273.35
debt to assets	0.3	0.28	3.60
net debt to ebitda	4.6	8.3	-44.61
current ratio	1.18	1.17	0.50
interest coverage	2.02	3.96	-48.92
income quality	-0.1	1.58	-106.28
dividend yield	0.01	0.01	11.01
payout ratio	0.05	0.03	96.91
sales general and administrative to revenue	0.0	0.04	-95.81
research and ddevelopement to revenue	0.0	0.01	-90.37
intangibles to total assets	0.0	0.18	-97.93
capex to operating cash flow	-1.98	0.1	-2,085.97
capex to revenue	0.0	0.01	-93.28
capex to depreciation	0.72	0.62	17.25
stock based compensation to revenue	0.0	0.0	-87.37
graham number	90.87	85.03	6.88
roic	0.15	0.22	-32.03
return on tangible assets	0.01	0.13	-91.34
graham net net	-514.21	-21.99	-2,238.75
working capital	1994400000	338000000	490.06
tangible asset value	1296700000	150000000	764.47
net current asset value	-7226500000	-342000000	-2,013.01
invested capital	2322400000	1018000000	128.13
average receivables	1799250000	2257400000	-20.30
average payables	5326650000	92000000	5,689.84
average inventory	525400000	480500000	9.34
days sales outstanding	10.9	133.08	-91.81
days payables outstanding	64.9	9.5	583.30
days of inventory on hand	3.3	49.77	-93.36
receivables turnover	33.49	2.74	1,120.89
payables turnover	5.62	38.43	-85.37
inventory turnover	110.48	7.33	1,406.47
roe	0.17	0.46	-62.00
capex per share	1.57	1.91	-17.87

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.17 on 2023-09-30 from 0.46 on 2022-09-30, representing a change of -62.00%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 8.11 on 2023-09-30 from 4.57 on 2022-09-30, representing a change of 77.38%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.18 on 2023-09-30 from 1.17 on 2022-09-30, representing a change of 0.50%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 4.70 on 2023-09-30 from 1.26 on 2022-09-30, representing a change of 273.35%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-06-30 Q3	2024-03-31 Q2	Q/Q change %
SNEX
calendar year	2024	2024	NaN
revenue per share	883.38	725.41	21.78
net income per share	2.02	1.74	15.93
operating cash flow per share	-9.08	26.91	-133.72
free cash flow per share	-9.68	26.34	-136.73
cash per share	167.31	104.47	60.15
book value per share	52.47	50.62	3.65
tangible book value per share	49.95	48.01	4.04
shareholders equity per share	52.47	50.62	3.65
interest debt per share	302.86	291.33	3.96
market cap	2297632384.6	2110314528	8.88
enterprise value	9081332384.6	7803314528	16.38
pe ratio	9.28	9.94	-6.60
price to sales ratio	0.08	0.1	-11.09
pocfratio	-8.26	2.57	-421.07
pfcf ratio	-7.75	2.63	-394.76
pb ratio	1.43	1.37	4.46
ptb ratio	1.43	1.37	4.46
ev to sales	0.34	0.35	-4.96
enterprise value over ebitda	21.36	21.85	-2.21
ev to operating cash flow	-32.65	9.52	-443.19
ev to free cash flow	-30.63	9.72	-415.06
earnings yield	0.03	0.03	7.07
free cash flow yield	-0.13	0.38	-133.93
debt to equity	5.57	5.58	-0.08
debt to assets	0.35	0.34	3.02
net debt to ebitda	15.96	15.94	0.13
current ratio	1.62	1.26	27.93
interest coverage	1.26	1.23	2.59
income quality	-4.66	16.02	-129.08
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.0	0.0	-19.40
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.0	0.0	-4.07
capex to operating cash flow	-0.07	0.02	-411.84
capex to revenue	0.0	0.0	-13.64
capex to depreciation	0.94	0.96	-1.81
stock based compensation to revenue	0.0	0.0	-2.36
graham number	48.83	44.55	9.62
roic	0.03	0.02	9.99
return on tangible assets	0.0	0.0	15.30
graham net net	-409.54	-454.21	9.84
working capital	7277000000	3247700000	124.07
tangible asset value	1530700000	1463100000	4.62
net current asset value	-5233400000	-8521600000	38.59
invested capital	7653700000	3607800000	112.14
average receivables	8751650000	9176550000	-4.63
average payables	11394150000	11076050000	2.87
average inventory	602150000	567650000	6.08
days sales outstanding	28.16	36.78	-23.42
days payables outstanding	38.09	48.96	-22.21
days of inventory on hand	2.01	2.59	-22.43
receivables turnover	3.2	2.45	30.58
payables turnover	2.36	1.84	28.54
inventory turnover	44.77	34.73	28.91
roe	0.04	0.03	11.85
capex per share	0.6	0.57	5.16

• Negative

  ROE: Return on Equity (ROE) increased to 0.04 on 2024-06-30 Q3 from 0.03 on 2024-03-31 Q2, representing a change of 11.85%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 9.28 on 2024-06-30 Q3 from 9.94 on 2024-03-31 Q2, representing a change of -6.60%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 5.57 on 2024-06-30 Q3 from 5.58 on 2024-03-31 Q2, representing a change of -0.08%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Positive

  Current Ratio: Current Ratio increased to 1.62 on 2024-06-30 Q3 from 1.26 on 2024-03-31 Q2, representing a change of 27.93%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None